Anisocoria Associated With Escitalopram
Authors:
- Atakan YucelAYAtakan Yucel
- Nermin YucelNYNermin Yucel
- Ali IbisAIAli Ibis
- Halil OzcanHOHalil Ozcan
- 1 August 2015
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 35 (4) , 483-484
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Clinical effectiveness and safety of escitalopram and desvenlafaxine in patients of depression with anxiety: A randomized, open-label controlled trialIndian Journal of Pharmacology, 2014
- Open-Label Treatment With Escitalopram in Patients With Social Anxiety Disorder and Fear of BlushingJournal of Clinical Psychopharmacology, 2013
- What is the optimal dose of escitalopram for the treatment of obsessive–compulsive disorder? A naturalistic open-label studyInternational Clinical Psychopharmacology, 2011
- Sertraline-Related AnisocoriaJournal of Clinical Psychopharmacology, 2010
- Anticholinergic Activity of 107 Medications Commonly Used by Older AdultsJournal of the American Geriatrics Society, 2008
- High-Dose Escitalopram Treatment in Patients With Obsessive-Compulsive DisorderJournal of Clinical Psychopharmacology, 2008
- New Possibilities of Treatment for Panic Attacks in Elderly PatientsJournal of Clinical Psychopharmacology, 2006
- Citalopram Therapy for DepressionThe Journal of Clinical Psychiatry, 2000
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981